B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 9, Issue 8, Pages 761-772
Publisher
Informa UK Limited
Online
2013-08-24
DOI
10.1586/1744666x.2013.816479
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-cell-targeted therapies in systemic lupus erythematosus
- (2013) Vera Sau-Fong Chan et al. Cellular & Molecular Immunology
- Rituximab biosimilars
- (2013) Edward M Vital et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Which are the antibodies to watch in 2013?
- (2013) Janice M. Reichert mAbs
- B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design
- (2013) Venkat Reddy et al. ARTHRITIS RESEARCH & THERAPY
- B-cell-depleting Therapy in Systemic Lupus Erythematosus
- (2012) Manuel Ramos-Casals et al. AMERICAN JOURNAL OF MEDICINE
- Recent progress in conventional and biologic therapy for systemic lupus erythematosus
- (2012) David Wofsy ANNALS OF THE RHEUMATIC DISEASES
- Immune Regulatory Function of B Cells
- (2012) Claudia Mauri et al. Annual Review of Immunology
- Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus
- (2012) Kenneth C. Kalunian et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
- (2012) J. C. Jennette et al. ARTHRITIS AND RHEUMATISM
- A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma
- (2012) D. S. Siegel et al. BLOOD
- BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
- (2012) Fabien B Vincent et al. IMMUNOLOGY AND CELL BIOLOGY
- Taming lupus—a new understanding of pathogenesis is leading to clinical advances
- (2012) Zheng Liu et al. NATURE MEDICINE
- Genetically Distinct Subsets within ANCA-Associated Vasculitis
- (2012) Paul A. Lyons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rationale of anti-CD19 immunotherapy: an option to target autoreactive plasma cells in autoimmunity
- (2012) Henrik E Mei et al. ARTHRITIS RESEARCH & THERAPY
- B cell biomarkers of rituximab responses in systemic lupus erythematosus
- (2011) Edward M. Vital et al. ARTHRITIS AND RHEUMATISM
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus
- (2011) Richard Furie et al. ARTHRITIS AND RHEUMATISM
- Immune regulatory mechanisms in ANCA-associated vasculitides
- (2011) Nikola Lepse et al. AUTOIMMUNITY REVIEWS
- Regulatory T cells in systemic lupus erythematosus (SLE); Role of peptide tolerance
- (2011) Priya Sawla et al. AUTOIMMUNITY REVIEWS
- B-cell depleting agents for ANCA vasculitides: A new therapeutic approach
- (2011) José A. Gómez-Puerta et al. AUTOIMMUNITY REVIEWS
- Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
- (2011) Cándido Díaz-Lagares et al. AUTOIMMUNITY REVIEWS
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Assessment of flares in lupus patients enrolled in a phase II/III study of rituximab (EXPLORER)
- (2011) JT Merrill et al. LUPUS
- The efficacy and safety of abatacept in patients with non-life-threatening manifestations of systemic lupus erythematosus: Results of a twelve-month, multicenter, exploratory, phase IIb, randomized, double-blind, placebo-controlled trial
- (2010) J. T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Ofatumumab, a human anti-CD20 monoclonal antibody, for treatment of rheumatoid arthritis with an inadequate response to one or more disease-modifying antirheumatic drugs: Results of a randomized, double-blind, placebo-controlled, phase I/II study
- (2010) Mikkel Østergaard et al. ARTHRITIS AND RHEUMATISM
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- ANCA in the diagnosis of neutrophil-mediated inflammation
- (2010) Ivo Lochman et al. AUTOIMMUNITY REVIEWS
- Treatment of systemic lupus erythematosus with epratuzumab
- (2010) Pawel Traczewski et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Targeting BAFF in autoimmunity
- (2010) Anne Davidson CURRENT OPINION IN IMMUNOLOGY
- The immunological basis of B-cell therapy in systemic lupus erythematosus
- (2010) Mo Yin MOK International Journal of Rheumatic Diseases
- B cells as therapeutic targets in SLE
- (2010) Iñaki Sanz et al. Nature Reviews Rheumatology
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus
- (2009) Daniel J. Wallace et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- The role of B cells in lupus pathogenesis
- (2009) Emil Nashi et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- CD20 deficiency in humans results in impaired T cell–independent antibody responses
- (2009) Taco W. Kuijpers et al. JOURNAL OF CLINICAL INVESTIGATION
- Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
- (2009) S Dolff et al. LUPUS
- Rituximab in systemic lupus erythematosusA systematic review of off-label use in 188 cases
- (2009) M Ramos-Casals et al. LUPUS
- Reduction of fatigue in Sjogren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study
- (2008) S Dass et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
- (2008) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Abetimus sodium for renal flare in systemic lupus erythematosus: Results of a randomized, controlled phase III trial
- (2008) Mario H. Cardiel et al. ARTHRITIS AND RHEUMATISM
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
- Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
- (2008) Jesús F. San Miguel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Multiple signaling pathways promote B lymphocyte stimulator dependent B-cell growth and survival
- (2007) R. T. Woodland et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now